An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2010.82
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

A Preliminary and Comparative Evaluation of a Novel Ad5 [E1-, E2b-] Recombinant-Based Vaccine Used to Induce Cell Mediated Immune Responses

Immunology Letters
AllergyImmunology
2009English

HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology

Clinical Investigation
2014English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Systematic Assessment of HER2/neu in Gynecologic Neoplasms, an Institutional Experience

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy